Human Microbiome Market, By Product (Obesity, Diabetes, Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, and Other Diseases), By Disease (Probiotics, Prebiotics, Synbiotic, and Other Products), By Application (Therapeutic and Diagnostic), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI378719 | Publish Date: April 2022 | No. of Pages: 168

Global Human Microbiome Market By Overview

Global Human Microbiome Market accounted for US$ 590.39 million in 2020 and is estimated to be US$ 3657.31 million by 2030 and is anticipated to register a CAGR of 19.8%. 

Human microbiome are present inside the surface of human body, for example skin, intestine, mouth covered with individual microbes. These human microbes are not harmful for human health. These essential microorganisms helps to perform the functions of body properly. The human microbiome helps us to keep infected harmful microbes away, these microorganisms are also called as the normal body flora. The organs with the human microbes are considered as the sterile organs.     

Global Human Microbiome Market By Dynamics

Growing prevalence of chronic diseases

Changing lifestyle and growing prevalence of chronic diseases, mainly cardiovascular diseases, cancer, type 2 diabetes mellitus, and respiratory diseases are the major driving factor for the growth of global market. As per the data of WHO (World’s Health Organization), globally in 2016, cardiovascular diseases (CVD) are the main cause of death, around 17.9 million people died due to CVDs, which represented 31% of all deaths, globally. Most of these deaths were due to cardiac arrests and strokes, and were observed mostly in the low- and middle-income countries. Additionally, the increasing geriatric population is the propelling factor for the growth of target market. Moreover, the human microbes are used to diagnosis the boosting factor for the growth of target market. However, lack of comprehensive in the research and development of the human microbes is the major restraining factor for the growth global human microbiome market. In addition, the strict rules and regulation on the experiments on human is the hampering factor for the growth of target market.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Human Microbiome Market By Segmentation

 

Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

The global human microbiome market is segmented based on product, disease, application, and region.

On the basis of product, the global human microbiome market is segmented into obesity, diabetes, autoimmune disorder, cancer, gastrointestinal disorders, central nervous system disorders, and other diseases. On the basis of disease, the target market is segmented into probiotics, prebiotics, synbiotic, and other products. Based on application, the global market is classified into therapeutic and diagnostic.

Regional Insights:

Based on region, the global human microbiome market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global market in North America region is seen to have a matured growth since this market correlates with the increasing growth rate of disease. In North America region the increasing awareness about human microbes is driving growth of the global market in this region. Moreover, investments into research and development for the better healthcare is anticipated to create growth opportunities for the Asia Pacific human microbiome market.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Global Human Microbiome Market, By Product:

  • Obesity
  • Diabetes
  • Autoimmune Disorder
  • Cancer
  • Gastrointestinal Disorders
  • Central Nervous System Disorders
  • Other Diseases

Global Human Microbiome Market, By Disease:

  • Probiotics
  • Prebiotics
  • Synbiotic
  • Other Products

Global Human Microbiome Market, By Application:

  • Therapeutic
  • Diagnostic

Global Human Microbiome Market, By Region:

      • North America
        • North America Human Microbiome Market, By Product
        • North America Human Microbiome Market, By Disease
        • North America Human Microbiome Market, By Application
        • North America Human Microbiome Market, By Country
          • U.S.
          • Canada
      • Europe
        • Europe Human Microbiome Market, By Product
        • Europe Human Microbiome Market, By Disease
        • Europe Human Microbiome Market, By Application
        • Europe Human Microbiome Market, By Country
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
        • Asia Pacific Human Microbiome Market, By Product
        • Asia Pacific Human Microbiome Market, By Disease
        • Asia Pacific Human Microbiome Market, By Application
        • Asia Pacific Human Microbiome Market, By Country
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific                                                                                                                                                                                           
      • Latin America
        • Latin America Human Microbiome Market, By Product
        • Latin America Human Microbiome Market, By Disease
        • Latin America Human Microbiome Market, By Application
        • Latin America Human Microbiome Market, By Country
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
        • Middle East & Africa Human Microbiome Market, By Product
        • Middle East & Africa Human Microbiome Market, By Disease
        • Middle East & Africa Human Microbiome Market, By Application
        • Middle East & Africa Human Microbiome Market, By Country
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Human Microbiome Market By Key Players

The key players operating the global human microbiome market involves Enterome Bioscience, Yakult, Dow DuPont Inc., Seres Therapeutics, ViThera Pharmaceuticals, Second Genome Inc., MatriSys Bioscience, Caelus Health, Rebiotix Inc., Assembly Biosciences Inc. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.

Global Human Microbiome Market By Company Profile

  • Enterome Bioscience *
  • Company Overview
  • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Yakult
  • Dow DuPont Inc.
  • Seres Therapeutics
  • ViThera Pharmaceuticals
  • Second Genome Inc.
  • MatriSys Bioscience
  • Caelus Health
  • Rebiotix Inc.
  • Assembly Biosciences Inc.

“*” marked represents similar segmentation in other categories in the respective section

Global Human Microbiome Market By Table of Contents

Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    •  Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Industry Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Human Microbiome Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product
      • Market Snippet, By Disease
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Human Microbiome Market, By Product, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Obesity
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Diabetes
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Autoimmune Disorder
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cancer
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Gastrointestinal Disorders
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Central Nervous System
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Products
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Human Microbiome Market, By Disease, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Probiotics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Prebiotics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Symbiotic
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Products
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Human Microbiome Market, By Application, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Therapeutics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Diagnostic
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Human Microbiome Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
      • Enterome Bioscience
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Yakult
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Dow DuPont Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Seres Therapuetics
        • Company Overview
        • Produpuct Portfolio
        • Key Highlights
        • Financial Overview
      • ViThera Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Second Genome Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • MatriSys Bioscience
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Caelus Health
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Rebiotix Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Assembly Biosciences Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
  11. The Last Word
    • Future Impact
    • About Us
    • Contact

 

FAQs

The Global Human Microbiome Market is valued at US$510.12 million in 2020.

The Global Human Microbiome Market is projected to increase at a CAGR of 18.2% during the forecast period.

The global human microbiome market is segmented based on product, disease, application, and region.

Changing lifestyle and growing prevalence of chronic diseases, mainly cardiovascular diseases, cancer, type 2 diabetes mellitus, and respiratory diseases are the major driving factor for the growth of global market.

Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.